Trial
NCT04129151
Palbociclib + Ganitumab In Ewing Sarcoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
1 Million 4 Anna Foundation; Carson Sarcoma Foundation; Teaming up to Fight Childhood Cancer; ChemoWarrior: the eli sidler foundation; i-ROK Foundation; Rutledge Cancer Foundation; Alan B. Slifka Foundation
Condition
Ewing Sarcoma
Intervention
Palbociclib
Why stopped
The study closed early due to discontinuation of ganitumab supply.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-01